Atracurium Besylate Injection. USP 50 mg

    Send Enquiry

    Atracurium Besylate Injection is indicated as an adjunct to general anaesthesia during surgery to relax skeletal muscles and facilitate endotracheal intubation and mechanical ventilation. Facilitating mechanical ventilation in an intensive care unit (ICU) patients is also suggested. Atracurium Besilate Injection should only be administered by intravenous injection. Do not give Atracurium Besylate Injection intramuscularly since this may result in tissue irritation and there are no clinical data to support this route of administration.

    To avoid distress to the patient, Atracurium Besilate Injection should not be administered before unconsciousness has been induced. Atracurium Besilate Injection should not be mixed in the same syringe, or administered simultaneously through the same needle, with alkaline solutions (e.g. barbiturate solutions).